LEXARIA BIOSCIENCE CORP. (LEXX) Operating cash flow 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.5MFY2025 · since FY2016: -$660,856 → -$10.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.5M | -110.7% |
| FY2024 | -$5.0M | +15.7% |
| FY2023 | -$5.9M | -20.5% |
| FY2022 | -$4.9M | -22.3% |
| FY2021 | -$4.0M | -52.3% |
| FY2020 | -$2.6M | +12.9% |
| FY2019 | -$3.0M | -19.4% |
| FY2018 | -$2.5M | -62.9% |
| FY2017 | -$1.5M | -133.9% |
| FY2016 | -$660,856 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LEXX financial trends
LEXX RevenueLEXX Net incomeLEXX Net marginLEXX Gross profitLEXX Gross marginLEXX Operating incomeLEXX Operating marginLEXX Free cash flowLEXX Capital expendituresLEXX Return on equityLEXX Stock buybacksLEXX Dividends paidLEXX Total assetsLEXX Total liabilitiesLEXX Shareholders’ equityLEXX overview →